Molecular Devices Corporation is a leading supplier of high-performance bioanalytical measurement systems that accelerate and improve drug discovery and other life sciences research.
The company's systems and consumables enable pharmaceutical and biotechnology companies to leverage advances in genomics and combinatorial chemistry by facilitating the high-throughput and cost-effective identification and evaluation of drug candidates. Molecular Devices' product solutions are based on the company's advanced core technologies that integrate its expertise in engineering, molecular and cell biology, electrophysiology, and chemistry. The company enables its customers to improve their research productivity and effectiveness, which ultimately accelerates the complex process of discovering and developing new drugs. Molecular Devices is based in Sunnyvale, California, and has offices in Union City, California, Downingtown, Pennsylvania, England, Germany, Norway, Korea, China and Japan.
Founded in 1983, Molecular Devices introduced its first microplate reader in 1987 and since then has continually broadened its solution set through a combination of internal R&D and acquisition. The company's most recent acquisitions of Universal Imaging Corporation (2002) and Axon Instruments (2004) broadened its portfolio to include electrophysiology products, scanners and analysis software for microarrays, and workstations for cell-based screening using high-resolution imaging.